Showing results (81-90 of 90) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Behavioural Brain Research|May 31, 2019
Immediate pre-learning stress enhances baseline startle response and fear acquisition in a fear-potentiated startle paradigmMackenzie R Riggenbach, Jordan N Weiser, Brianne E Mosley, et al.Molecular Psychiatry|August 27, 2024
Markers of positive affect and brain state synchrony discriminate melancholic from non-melancholic depression using naturalistic stimuliPhilip E Mosley, Johan N van der Meer, Lachlan H W Hamilton, et al.Biological Psychiatry|September 6, 2021
Connectomic Deep Brain Stimulation for Obsessive-Compulsive DisorderJuan Carlos Baldermann, Thomas Schüller, Sina Kohl, et al.BMJ Open|February 26, 2022
Australian Parkinson's Genetics Study (APGS): pilot (n=1532)Svetlana Bivol, George D Mellick, Jacob Gratten, et al.Neuroimage. Clinical|December 20, 2020
A prospective cohort study of prodromal Alzheimer's disease: Prospective Imaging Study of Ageing: Genes, Brain and Behaviour (PISA)Michelle K Lupton, Gail A Robinson, Robert J Adam, et al.Nature Neuroscience|August 8, 2017
Antipsychotic-induced Hdac2 transcription via NF-κB leads to synaptic and cognitive side effectsDaisuke Ibi, Mario de la Fuente Revenga, Nebojsa Kezunovic, et al.Cancer Cell|November 14, 2018
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic CancerWei Wang, Jill M Marinis, Allison M Beal, et al.Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
Deep brain stimulation and psychosis: A case series and two candidate causal brain circuitsGarance M Meyer, Andrew R Pines, Alexandra Roldan, et al.Journal of Medicinal Chemistry|April 24, 2019
Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) KinasePhilip A Harris, Nicolas Faucher, Nicolas George, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 15, 2023
Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA-PD StudyRebecca Kerestes, Max A Laansma, Conor Owens-Walton, et al.Pageof 9